buttonPrevHTML: ”,
};
function adaptBreadcrumbs() {
let breadcrumbs = document.querySelectorAll(‘#header-breadcrumbs’);
for(i = 0; i < breadcrumbs.length; i++) {
let title = breadcrumbs[i].querySelector(‘.breadcrumbs-title’);
let btns = breadcrumbs[i].querySelector(‘.btn-container:last-child’);
if(btns && btns.children && btns.children.length) {
if(parseInt(title.getBoundingClientRect().top + title.getBoundingClientRect().height / 2) == parseInt(btns.getBoundingClientRect().top + btns.getBoundingClientRect().height / 2)) {
title.style=”flex-grow:1;”;
} else {
title.style=”flex-grow:0;”;
}
} else {
title.style=”flex-grow:1;”;
}
}
}
window.addEventListener(‘resize’, adaptBreadcrumbs);
document.addEventListener(‘DOMContentLoaded’, adaptBreadcrumbs);
The FTSE 100 ended Tuesday marginally lower but staged a solid recovery from its intraday lows as sentiment improved in the afternoon, echoing a broader easing of losses across global markets. The rebound coincided with a pullback in oil prices: Brent crude, which had neared $112 a barrel earlier in the session, slipped back below $108. Strength in healthcare stocks AstraZeneca (+1.5%) and GSK (+0.6%) was more than offset by weakness across energy, banking, mining and defence names. Shell and BP declined, while HSBC and Lloyds Banking Group each lost around 1%. NatWest and Standard Chartered were down about 2%, Rio Tinto and Glencore fell by more than 2%, and Rolls-Royce and BAE Systems eased 0.7% and 0.5%, respectively. On the macroeconomic front, UK payroll employment rose by 13,000 in September, defying expectations for an 8,000 drop. The unemployment rate slipped to 4.7% in the three months to August, its lowest level since July 2025.